Dr. Piccart Explains the Benefit of the IMPAKT Conference

Martine Piccart, MD, PhD
Published: Thursday, Apr 11, 2013

Martine Piccart, MD, PhD, director of medicine at the Jules Bordet Institute in Brussels, Belgium, gives an overview of the IMPAKT conference.

Piccart has been impressed by the exponential growth in information related to cancer biology and new technologies in recent years. She felt that there was a need to educate young medical oncologists on these technologies, including how to interpret results.

The conference usually has between 600 and 700 people attend and features a course to explain new technologies to pathologists, who have to cope with this rapidly changing field.

SELECTED
LANGUAGE
Martine Piccart, MD, PhD, director of medicine at the Jules Bordet Institute in Brussels, Belgium, gives an overview of the IMPAKT conference.

Piccart has been impressed by the exponential growth in information related to cancer biology and new technologies in recent years. She felt that there was a need to educate young medical oncologists on these technologies, including how to interpret results.

The conference usually has between 600 and 700 people attend and features a course to explain new technologies to pathologists, who have to cope with this rapidly changing field.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Community Practice Connections™: How Do We Leverage PARP Inhibition Strategies in the Contemporary Treatment of Breast Cancer?May 31, 20191.5
Publication Bottom Border
Border Publication
x